Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000175

Chairperson & CEO sold 9,500 shares at an average $594.78 ($5,650,415)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-29 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-29 Sale : show line 2 in the form 10b5-1 −53 $590.43 $31,293 333,890 I
2026-10-29 Sale : show line 3 in the form 10b5-1 −1,104 $591.90 $653,460 332,786 I
2026-10-29 Sale : show line 4 in the form 10b5-1 −1,563 $592.97 $926,810 331,223 I
2026-10-29 Sale : show line 5 in the form 10b5-1 −1,540 $593.88 $914,574 329,683 I
2026-10-29 Sale : show line 6 in the form 10b5-1 −1,248 $594.89 $742,429 328,435 I
2026-10-29 Sale : show line 7 in the form 10b5-1 −1,678 $595.88 $999,886 326,757 I
2026-10-29 Sale : show line 8 in the form 10b5-1 −1,355 $596.86 $808,746 325,402 I
2026-10-29 Sale : show line 9 in the form 10b5-1 −919 $597.66 $549,245 324,483 I
2026-10-29 Sale : show line 10 in the form 10b5-1 −40 $599.30 $23,972 324,443 I
Open-market sales · 9,500 sh · avg $594.78 · $5,650,415

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-29 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option −9,500 128,910 I
Loading xslF345X06/primarydocument.xml…